Exponent [EXPO] vs Argan [AGX] Detailed Stock Comparison

Exponent Inc.

NASDAQ
Loading...

Argan Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Exponent Inc. wins in 10 metrics, Argan Inc. wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

Metric Exponent Inc. Argan Inc. Better
P/E Ratio (TTM) 32.99 67.11 Exponent Inc.
Price-to-Book Ratio 8.68 19.67 Exponent Inc.
Debt-to-Equity Ratio 21.22 1.38 Argan Inc.
PEG Ratio 5.06 1.26 Argan Inc.
EV/EBITDA 24.83 59.86 Exponent Inc.
Profit Margin (TTM) 19.75% 14.59% Exponent Inc.
Operating Margin (TTM) 22.52% 18.19% Exponent Inc.
EBITDA Margin (TTM) 22.52% 18.19% Exponent Inc.
Return on Equity 26.13% 33.85% Argan Inc.
Return on Assets (TTM) 9.63% 8.33% Exponent Inc.
Free Cash Flow (TTM) $122.34M $410.84M Argan Inc.
Dividend Yield 1.98% 0.48% Exponent Inc.
1-Year Return -23.60% 217.18% Argan Inc.
Price-to-Sales Ratio (TTM) 6.27 9.63 Exponent Inc.
Enterprise Value $3.22B $8.20B Argan Inc.
EV/Revenue Ratio 6.01 8.68 Exponent Inc.
Gross Profit Margin (TTM) N/A 25.03% N/A
Revenue per Share (TTM) $11 $69 Argan Inc.
Earnings per Share (Diluted) $2.07 $9.71 Argan Inc.
Beta (Stock Volatility) 0.80 0.46 Argan Inc.
Short % of Float 8.60% 5.96% Argan Inc.

Exponent Inc. vs Argan Inc. Stock Performance Analysis

Loading Price Chart...

EXPO
AGX

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Exponent Inc.-0.14%1.51%-10.11%-20.86%-20.25%-16.76%
Argan Inc.3.54%-1.12%-4.88%48.90%85.50%103.44%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Exponent Inc.-23.60%-38.21%-34.09%113.16%467.32%1,418.75%
Argan Inc.217.18%1,524.11%1,277.00%1,854.35%7,352.74%24,604.44%

Performance & Financial Health Analysis: Exponent Inc. vs Argan Inc.

MetricEXPOAGX
Market Information
Market Cap i$3.26B$9.17B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i485,347315,927
90 Day Avg. Volume i502,606529,472
Last Close$58.31$686.59
52 Week Range$51.91 - $81.95$193.82 - $748.50
% from 52W High-28.85%-8.27%
All-Time High$127.61 (Nov 22, 2021)$741.40 (May 05, 2026)
% from All-Time High-54.31%-7.39%
Growth Metrics
Quarterly Revenue Growth0.05%0.13%
Quarterly Earnings Growth0.05%0.57%
Financial Health
Profit Margin (TTM) i0.20%0.15%
Operating Margin (TTM) i0.23%0.18%
Return on Equity (TTM) i0.26%0.34%
Debt to Equity (MRQ) i21.221.38
Cash & Liquidity
Book Value per Share (MRQ)$7.87$33.14
Cash per Share (MRQ)$4.51$64.18
Operating Cash Flow (TTM) i$131.73M$414.72M
Levered Free Cash Flow (TTM) i$95.01M$340.95M
Dividends
Last 12-Month Dividend Yield i1.98%0.48%
Last 12-Month Dividend i$1.51$1.76

Valuation & Enterprise Metrics Analysis: Exponent Inc. vs Argan Inc.

MetricEXPO (Apr 24, 2026)AGX (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i32.9967.11
Forward P/E i25.1143.68
PEG Ratio i5.061.26
Price to Sales (TTM) i6.279.63
Price to Book (MRQ) i8.6819.67
Market Capitalization
Market Capitalization i$3.26B$9.17B
Enterprise Value i$3.22B$8.20B
Enterprise Value Metrics
Enterprise to Revenue i6.018.68
Enterprise to EBITDA i24.8359.86
Risk & Other Metrics
Beta i0.800.46
Book Value per Share (MRQ) i$7.87$33.14

Financial Statements Comparison: Exponent Inc. vs Argan Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricEXPO (2025)AGX (2026)
Revenue/Sales i582.01M944.61M
Cost of Goods Sold iN/A750.93M
COGS % of Revenue i0.0%79.5%
Gross Profit iN/A193.68M
Gross Margin i0.0%20.5%
Research & Development iN/AN/A
Operating Income (EBIT) i119.79M134.70M
Operating Margin i20.6%14.3%
EBITDA i112.67M140.87M
EBITDA Margin i19.4%14.9%
Pre-Tax Income i147.30M160.51M
Pre-Tax Income % of Revenue i25.3%17.0%
Income Tax i41.29M22.74M
Income Tax % of Revenue i7.1%2.4%
Net Income (Profit) i106.01M137.77M
Profit Margin i18.2%14.6%

Balance Sheet & Liquidity Metrics

MetricEXPO (2025)AGX (2026)
Cash & Equivalents i221.93M339.48M
Total Current Assets i427.58M1.13B
Total Current Assets % of Revenue i73.5%119.9%
Total Current Liabilities i178.00M711.26M
Total Current Liabilities % of Revenue i30.6%75.3%
Long-Term Debt i75.94MN/A
Long-Term Debt % of Revenue i13.0%0.0%
Total Shareholders Equity i390.34M462.26M
Retained Earnings i668.42M406.20M
Retained Earnings % of Revenue i114.8%43.0%
Property, Plant & Equipment i73.38M0

Cash Flow Statement Comparison

MetricEXPO (2025)AGX (2026)
Operating Cash Flow i120.26M386.08M
Operating Cash Flow % of Revenue i20.7%40.9%
Capital Expenditures iN/A-3.88M
Free Cash Flow i122.34M410.84M
FCF Margin i21.0%43.5%
Debt Repayment iN/AN/A
Common Stock Repurchase i-97.10M-9.88M

Short Interest & Institutional Ownership Analysis

MetricEXPOAGX
Shares Short i3.22M795,305
Short Ratio i6.391.23
Short % of Float i8.60%5.96%
Shares Outstanding i49.62M13.95M
Float Shares i48.69M13.38M
% Held by Insiders i1.23%4.26%
% Held by Institutions i99.46%93.49%
% Held by Public i-0.69%2.25%

Dividend Analysis & Yield Comparison: Exponent Inc. vs Argan Inc.

MetricEXPOAGX
Last 12-Month Dividend i$1.51$1.76
Last 12-Month Dividend Yield i1.98%0.48%
3-Year Avg Annual Dividend i$1.22$1.41
3-Year Avg Dividend Yield i0.33%0.39%
3-Year Total Dividends i$3.67$4.22
Ex-Dividend DateMar 06, 2026Jan 22, 2026